WHO ICTRP trial
Clinical Study to Evaluate the Efficacy and Safety in Healthy Adults for a…
CTRI/2024/05/066815 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/05/066815 |
|---|---|
| Public title | Clinical Study to Evaluate the Efficacy and Safety in Healthy Adults for a period of 2 months for the safety endpoints. |
| Scientific title | A Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Meet Shilajeet Supplement on Improving Vitality, Boosting stamina, Strength and Performance in Healthy Adults. - NIL |
| Primary sponsor | Herbal Creations |
| Secondary sponsors | Not Applicable |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Interventions | Intervention1: Meet Shilajeet: Route of Administration: Oral dosage Quantity: Meet Shilajeet supplement 500 mg capsule Twice a day treatment for 2 months Control Intervention1: Microcrystalline cellulose Capsules supplement (250 mg capsule)… |
| Registration date | Jun 5, 2024 |
| Target size | 50 |
| Secondary IDs | TG/CLI/083, Version 2.0, 08 Apr 2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: